Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,074 public trials 1,776 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Alzheimer's Disease Neuroimaging Initiative 2

NCT01231971

Conditions
Alzheimer Disease, Alzheimer's Disease (AD), Brain Diseases, +19 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • Banner Alzheimer's Institute Phoenix, Arizona, United States
  • Banner Sun Health Research Institute Sun City, Arizona, United States
  • University of California, Irvine Irvine, California, United States
View all 58 locations
View Trial Details
Completed

Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)

NCT03631407

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +19 more
Locations
  • Honor Health ( Site 0103) Scottsdale, Arizona, United States
  • California Cancer Associates for Research & Excellence ( Site 0100) Encinitas, California, United States
  • California Cancer Associates for Research & Excellence ( Site 0102) Fresno, California, United States
  • Florida Cancer Specialists (South Region) - Research Office ( Site 7001) Fort Myers, Florida, United States
View Trial Details
Completed

Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)

NCT03374254

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +20 more
Locations
  • City of Hope National Medical Center ( Site 0102) Duarte, California, United States
  • Anschutz Medical Campus, Anschutz Cancer Pavilion ( Site 0106) Aurora, Colorado, United States
  • Yale Cancer Center ( Site 0108) New Haven, Connecticut, United States
  • Moffitt Cancer Center ( Site 0111) Tampa, Florida, United States
View all 14 locations
View Trial Details
Completed

A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Conditional Labeling

NCT03884231

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Banner University Medical Center Tucson Campus Tucson, Arizona, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Neurosurgery One Littleton, Colorado, United States
  • Emory University Hospital Atlanta, Georgia, United States
View all 16 locations
View Trial Details
Completed

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

NCT03393520

Conditions
Aberrant Motor Behavior in Dementia, Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, +17 more
Locations
  • MD First Research #767 Chandler, Arizona, United States
  • Liv Generations of Agritopia / CCT #573 Gilbert, Arizona, United States
  • Liv Generations of Ahwatukee / CCT #784 Phoenix, Arizona, United States
  • Perseverance Research Center Scottsdale, Arizona, United States
View all 211 locations
View Trial Details
Completed

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

NCT01767909

Conditions
Alzheimer Disease, Alzheimer's Disease, Amnestic Mild Cognitive Impairment, +15 more
Locations
  • Banner Alzheimer's Institute Phoenix, Arizona, United States
  • Barrow Neurology Clinics Phoenix, Arizona, United States
  • University of California, Irvine Irvine, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
View all 25 locations
View Trial Details

Related conditions